NASDAQ:BTAI - BioXcel Therapeutics Price Target & Analyst Ratings

$8.82
-0.02 (-0.23 %)
(As of 08/20/2019 09:45 AM ET)
Today's Range
$8.82
Now: $8.82
$8.82
50-Day Range
$8.01
MA: $10.20
$11.40
52-Week Range
$2.41
Now: $8.82
$12.00
Volume360 shs
Average Volume27,402 shs
Market Capitalization$138.74 million
P/E RatioN/A
Dividend YieldN/A
Beta3.02

Analyst Ratings

BioXcel Therapeutics (NASDAQ:BTAI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for BioXcel Therapeutics in the last 12 months. Their average twelve-month price target is $23.00, suggesting that the stock has a possible upside of 160.77%. The high price target for BTAI is $25.00 and the low price target for BTAI is $21.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $23.00$23.00$23.00$20.40
Price Target Upside: 160.77% upside111.20% upside150.82% upside209.09% upside

BioXcel Therapeutics (NASDAQ:BTAI) Consensus Price Target History

BioXcel Therapeutics (NASDAQ:BTAI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/5/2019HC WainwrightSet Price TargetBuy$25.00LowView Rating Details
3/8/2019Canaccord GenuitySet Price TargetBuy$21.00HighView Rating Details
4/2/2018BMO Capital MarketsInitiated CoverageOutperform$23.00HighView Rating Details
4/2/2018UBS GroupInitiated CoverageBuy$18.00HighView Rating Details
4/2/2018BarclaysInitiated CoverageOverweight ➝ Overweight$15.00HighView Rating Details
(Data available from 8/20/2017 forward)
This page was last updated on 8/20/2019 by MarketBeat.com Staff

Featured Article: Bond

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel